Watermark
  Back to Search Results

BGB-A317-LBL-007-201

Active, not recruiting

A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-LBL-007-201

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05609370

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20223077

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan